Mersana Therapeutics inc (MRSN) - News Archive

Showing 4 of 4 results.

Mersana Therapeutics Strengthens Talent Acquisition Strategy with New Inducement Award Amidst Ongoing Cancer Research Initiatives

Mersana Therapeutics Enhances Talent with Inducement Award Amidst Ongoing Oncology InnovationsAs Mersana Therapeutics, Inc. embarks on a pivotal year in its quest to combat cancers with innovative therapies, the company...

Feb 7, 2025 • Major Pharmaceutical Preparations Industry Stock Market Announcement

Mersana Therapeutics Enhances Cancer Research Efforts Through Inducement Grant to New Employee

Mersana Therapeutics Grants Inducement Award to New Employee, Reflecting the Company s Commitment towards Cancer ResearchCAMBRIDGE, Mass., May 03, 2024 - Mersana Therapeutics, a renowned clinical-stage biopharmaceutical...

May 3, 2024 • Major Pharmaceutical Preparations Industry Clinical Study

Mersana Therapeutics Surges Ahead with Exciting Business Updates, 2024 Milestones, and Participation in Prestigious Healthcare Conference

Mersana Therapeutics, a renowned clinical-stage biopharmaceutical company, recently released some crucial business updates along with their anticipated milestones for the year 2024. Additionally, the company has announc...

Jan 5, 2024 Clinical Study

Mersana Therapeutics, a Cambridge-based biopharmaceutical company, has recently announced the granting of an inducement award to a new employee The award consists of a restricted stock unit (RSU) award, allowing the acquisition of 12,205 shares of the company's common stock This move is in line with Nasdaq Listing Rule 5635(c)(4) and aims to attract and incentivize talented individuals into joining Mersana's workforce

Mersana Therapeutics, a Cambridge-based biopharmaceutical company, has recently announced the granting of an inducement award to a new employee. The award consists of a restricted stock unit (RSU) award, allowing the ac...

Dec 1, 2023 Stock Market Announcement